Tue.Aug 27, 2024

article thumbnail

Eli Lilly rolls out direct patient access to weight loss star Zepboundā€”at a deep discount

Fierce Pharma

Eli Lilly has come up with a new way of supplying its popular weight-loss drug Zepbound that the company hopes could expand access while addressing other issues such as high prices and off-label co | Eli Lilly is offering its popular weight-loss drug Zepbound directly to consumers at a discount through its own online pharmacy. The company hopes the move could expand access while addressing other issues such as high prices and off-label cosmetic usage.

Patients 344
article thumbnail

Increasing Health Equity Through Accessibility and Education

MedCity News

Through community engagement, the root causes of healthcare disparities can be addressed, and the health and resiliency of individuals can be dramatically improved. The post Increasing Health Equity Through Accessibility and Education appeared first on MedCity News.

Education 118
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

SCOTUS overturn of Chevron doctrine opens a Pandora's box for biopharma industry, expert says

Fierce Pharma

For the last 40 years, when federal legislation was ambiguous or left an administrative gap, courts were required to defer to the interpretation of federal agencies. | In June, when the Supreme Court voted 6-3 to overturn the Chevron doctrine, it brought significant impact for the healthcare industry and federal regulators like the FDA and the Centers for Medicare & Medicaid Services.

Biopharma 312
article thumbnail

Pfizer joins Lilly in direct-to-consumer drive

pharmaphorum

Pfizer has become the latest big pharma group to launch a web-based platform that opens up a direct-to-consumer channel for medicines access.This morning, the company announced the launch in the US of PfizerForAll, a digital platform that it says provides access to same-day appointments with healthcare professionals ā€“ in-person or via a $35 telehealth visit ā€“ along with home delivery of medicines and diagnostics, vaccination appointments, and payment support.

Medicine 116
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

After guiding Endo through bankruptcy, CEO Blaise Coleman exits suddenly

Fierce Pharma

Four months after emerging from bankruptcy, Endo is in transition again with the sudden departure of CEO Blaise Coleman. | Four months after emerging from bankruptcy, Endo Pharmaceuticals is in transition again with the sudden departure of CEO Blaise Coleman. Without providing a reason, the Dublin-based company revealed Colemanā€™s eventful four-year tenure will end Thursday.

article thumbnail

Roche gets EU nod for subcutaneous PNH drug PiaSky

pharmaphorum

Roche's PiaSky is the first therapy for rare blood disorder PNH that can be given by monthly subcutaneous injection in the EU.

116
116

More Trending

article thumbnail

J&J's Balversa is first pan-FGFR bladder cancer drug in EU

pharmaphorum

J&J's Balversa has been approved in the EU for advanced bladder cancer with FGFR3 genetic alterations after one line of prior therapy

115
115
article thumbnail

National campaign launches to end prostate cancer postcode lottery

PharmaTimes

Over 135,000 people have signed a petition to prioritise a national screening programme

114
114
article thumbnail

MBX joins IPO queue with $100m Nasdaq filing

pharmaphorum

US biotech MBX Biosciences, files for an IPO, seeking around $100 million to take a hypoparathyroidism candidate into phase 3

113
113
article thumbnail

A Revolution in Military Medical Staffing is Afoot and Private Sector Firms are Playing a Big Part

MedCity News

No revolutionary naval vessels, fighter planes, or weapon systems were involved. Rather, this one was about staffing military healthcare facilities. Make no mistake, though: Itā€™s also revolutionary. The post A Revolution in Military Medical Staffing is Afoot and Private Sector Firms are Playing a Big Part appeared first on MedCity News.

Medical 111
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

After FDA no, Regeneron gets yes from EU on odronextamab

pharmaphorum

Regeneron's Ordspono (odronextamab) for non-Hodgin lymphoma (NHL) is cleared in EU five months after being turned down by the FDA

FDA 111
article thumbnail

Singapore approves mpox vaccine as it adds border infection checks

Pharmaceutical Technology

Unlike its close neighbour Thailand, Singapore has not yet confirmed an mpox clade Ib case.

111
111
article thumbnail

HDA 2024 Traceability Seminar: An FDA Perspective on DSCSA

Pharmaceutical Commerce

The agency provides an update surrounding the Actā€™s implementation efforts.

FDA 110
article thumbnail

As pharmaā€™s AI revolution gets underway, ā€˜hallucinationsā€™ pose a great risk

PharmaVoice

While AI, machine learning and large language models can distill huge amounts of information, they sometimes make mistakes. New technologies could rebuild that trust.

106
106
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but thatā€™s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers canā€™t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Pharma Pulse 8/27/24: Inside a Love-Hate Relationship With ChatGPT, Virtual Care's Role in Behavioral Health & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 105
article thumbnail

J&Jā€™s Change to 340B Discounts is ā€œInconsistentā€ with Statute, HRSA Says

MedCity News

Johnson & Johnson announced last week a major change in the way it offers 340B pricing for two medications. The change is “inconsistent” with the 340B statute, according to HRSA. The post J&Jā€™s Change to 340B Discounts is ā€œInconsistentā€ with Statute, HRSA Says appeared first on MedCity News.

Medical 99
article thumbnail

Improving tracking of AMR bacteria in hospitals using new genomic technique

PharmaTimes

The spread of multiple bacteria could be tracked simultaneously through sequencing method

80
article thumbnail

New Data Network Seeks to Provide Much-Needed Info on GLP-1s

MedCity News

OMNY Health ā€” a national data ecosystem that facilitates biotech and medical research ā€” launched a data network consisting of EHR data from more than 645,000 GLP-1 users. The data network seeks to give OMNYā€™s life sciences and health system partners a vast source of GLP-1 data that is related to patient demographics and social determinants of health.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Shortages improve for Lillyā€™s GLP-1 weight loss drugs, bumping sales forecast by $3bn

Pharmaceutical Technology

Eli Lilly and Novo Nordisk have announced that the supply of their GLP-1 weight loss drugs has improved with increased availability of Zepbound, Mounjaro, Wegovy, and Trulicity.

Sales 59
article thumbnail

Treatment With Pegcetacoplan Could Aid Individuals with C3G and Primary IC-MPGN

Pharmacy Times

Pegcetacoplan is a targeted C3 therapy that is intended to regulate excessive activation of the complement cascade.

52
article thumbnail

Roche Treatment for Paroxysmal Nocturnal Hemoglobinuria Approved in EU

PharmaTech

PiaSky (crovalimab) has previously been approved in countries such as the United States and Japan for monthly, subcutaneous use that may be self-administered with adequate training.

article thumbnail

Navigating Real Estate for Your Growing Medical Practice

Referral MD

Expanding your medical practice is an exciting venture, but it comes with its own challengesā€”especially regarding real estate. In the latest episode of our podcast , we dive deep into essential real estate tips tailored for growing medical practices. Whether you’re looking to lease new space, select the perfect location, or optimize your current practice layout, these expert insights will guide you through the process.

Medical 52
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

EC upgrades approval for J&Jā€™s Rybrevant/chemotherapy combination in NSCLC

Pharmaceutical Technology

Rybrevant has been granted a Type II approval extension to treat NSCLC with EGFR mutations following the failure of TKI therapy.

52
article thumbnail

Lilly Introduces Single-Dose Vials of Zepbound, Expanding Access for Adults with Obesity

Pharmaceutical Commerce

The new vials of Zepbound are available through a new self-pay pharmacy channel, priced over 50% lower than other incretin medications for obesity.

Medical 52
article thumbnail

Lilly Introduces Single-Dose Vials of Zepbound, Expanding Access for Adults with Obesity

PharmExec

The new vials of Zepbound are available through a new self-pay pharmacy channel, priced over 50% lower than other incretin medications for obesity.

Medical 52
article thumbnail

How demand forecasting can give health systems an edge over the competition

Clarify Health

For most health systems, achieving strategic growth necessitates precise, data-driven insights that anticipate future needs and inform impactful decisions. Clarify Healthā€™s advanced demand forecasting capabilities, embedded in the Clarify Atlas PlatformĀ®, empower healthcare organizations to navigate the future with a clear, strategic vision. By harnessing a comprehensive suite of data and analytics, healthcare providers can identify growth opportunities at a granular levelā€”from specific service

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Merck Launches Shorespan-007 Clinical Trial of Bomedemstat for Essential Thrombocythemia

PharmExec

Shorespan-007 is expected to enroll approximately 300 patients with essential thrombocythemia and will compare bomedemstat to hydroxyurea, the current standard of care.

article thumbnail

Pulsed field ablation re-energizes the atrial fibrillation market

Clarivate

Since the FDAā€™s approval of the first pulsed field ablation (PFA) system in the U.S. last December, PFA technology has rapidly reconfigured the electrophysiology market in the U.S. and ramped up sales of PFA systems in Europe. The shocking speed of PFAā€™s adoption continues to reverberate through the industry, but the benefit appears more widespread than early reports indicated.

article thumbnail

FDA Clears Insuletā€™s Omnipod Automated Insulin Delivery System for Type 2 Diabetes

PharmExec

Expanded indication makes Omnipod the first automated insulin delivery system to be approved for the management of both type 1 and type 2 diabetes.

FDA 52
article thumbnail

What is mpox and how big of a threat is it?

Pharmaceutical Technology

Declared a PHEIC by the WHO, an mpox outbreak in the DRC is posing a threat to human health.

52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A